Telix Pharmaceuticals Salute del bilancio
Salute finanziaria criteri di controllo 5/6
Telix Pharmaceuticals has a total shareholder equity of A$404.0M and total debt of A$11.9M, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are A$746.0M and A$342.0M respectively. Telix Pharmaceuticals's EBIT is A$67.4M making its interest coverage ratio -64.7. It has cash and short-term investments of A$118.8M.
Informazioni chiave
2.9%
Rapporto debito/patrimonio netto
AU$11.85m
Debito
| Indice di copertura degli interessi | -64.7x |
| Contanti | AU$118.84m |
| Patrimonio netto | AU$403.97m |
| Totale passività | AU$341.98m |
| Totale attività | AU$745.96m |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Recent updates
Analisi della posizione finanziaria
Passività a breve termine: TLPP.F's short term assets (A$255.3M) do not cover its short term liabilities (A$258.4M).
Passività a lungo termine: TLPP.F's short term assets (A$255.3M) exceed its long term liabilities (A$83.6M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: TLPP.F has more cash than its total debt.
Riduzione del debito: TLPP.F's debt to equity ratio has reduced from 3.3% to 2.9% over the past 5 years.
Copertura del debito: TLPP.F's debt is well covered by operating cash flow (419.4%).
Copertura degli interessi: TLPP.F earns more interest than it pays, so coverage of interest payments is not a concern.